Occupational Therapists in Mount Kisco, NY Accepting Medicare

11 Occupational Therapists found. Showing 1 - 11

Kara Allen, OTR/L Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 70 Barker St Apt 707, Mount Kisco, NY 10549 Phone: 914-864-0315    Fax: 914-864-0315

Anthony Robert Kwalwasser, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 101 S Bedford Rd Ste 404, Mount Kisco, NY 10549 Phone: 914-421-8270

Miss Leeann Gammarati, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 120 W Main St, Mount Kisco, NY 10549 Phone: 914-666-0914

Ms. Patricia Biederman Robbins, OTR/L Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 20 Peck Rd, Mount Kisco, NY 10549 Phone: 914-666-5052

Molly Bernson Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 101 S Bedford Rd Ste 404, Mount Kisco, NY 10549 Phone: 914-421-8270

Sophie Kinnarney Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 272 N Bedford Rd, Mount Kisco, NY 10549 Phone: 225-936-0492

Ms. Meridith Ellen Mcdowell-choate Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 47 W Hyatt Ave, Mount Kisco, NY 10549 Phone: 914-666-2677

Mrs. Tricia Zwaresh Sabini, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 120 Kisco Ave, Mount Kisco, NY 10549 Phone: 914-242-8720

Karolyn Ruth Kingman, MS, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 272 N Bedford Rd, Mount Kisco, NY 10549 Phone: 914-703-2353

Mrs. Lisa B Kalmanson, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 53 Park Dr, Mount Kisco, NY 10549 Phone: 914-498-3626    Fax: 914-244-0238

Ms. Rachel Taylor Blitzer Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 101 S Bedford Rd Ste 404, Mount Kisco, NY 10549 Phone: 914-421-8270

News Archive

Cellectar completes enrollment in (131)I-CLR1404 Phase I dosimetry trial for advanced solid malignancies

Cellectar, Inc., a privately held radiopharmaceutical company that designs and develops products to detect, treat and monitor human cancers, today announced that enrollment for its Phase I dosimetry trial for its lead drug candidate, (131)I-CLR1404 has been completed. Results of this trial will be used to set the starting dose in a follow-on Phase I dose escalation study planned for later this year. Institutions that participated in the trial include City of Hope, Duke University Medical Center, Georgetown University/Lombardi Cancer Center, and Johns Hopkins Hospital.

KineMed receives NIH RAID grant to advance FX-5A for heart disease

KineMed Inc. today announced its successful award of a Rapid Access to Intervention Development (RAID) peer-reviewed grant by the National Institute of Health to advance an HDL mimetic, designated FX-5A, designed to reverse atherosclerosis and heart disease.

Genetic testing for inherited blood-clotting abnormalities not routinely recommended for VTE patients

Genetic testing for inherited blood-clotting abnormalities is not routinely recommended for patients with venous thromboembolism (VTE) of unknown cause, according to a new expert panel statement in a recent issue of Genetics in Medicine, the official peer-reviewed journal of The American College of Medical Genetics (ACMG).

Scientists find new way to slow growth of triple negative breast cancer

CANCER RESEARCH UK scientists have found a new way to slow the growth of the most aggressive type of breast cancer, according to research published in the journal Oncogene today (Monday).

Do we age as a consequence of being protected against cancer?

The role of one of our genes which protects us from cancer but could also cause us to age will be explained in a lecture at the University of Leicester.

Read more Medical News

› Verified 1 days ago